PRECIOUS-Gold slips on hopes of recovery, vaccine; focus on U.S. payrolls
    July 2 (Reuters) - Gold edged lower on Thursday, easing from
a near eight-year peak hit in the last session, as solid U.S.
trial revived hopes for a quick economic recovery, denting
0703 GMT, after touching $1,788.96 on Wednesday, its highest
    U.S. gold futures        fell 0.1% to $1,778.
seeing a little bit of pressure on gold," said Michael McCarthy,
chief strategist at CMC Markets, adding that market action
for a vaccine and positive U.S. data.
June, hitting its highest in more than a year, while similar
high price of gold," Phillip Futures said in a note.
    Markets now await June U.S. employment data and weekly
U.S. economy as new cases accelerate in several southern states.
    Economists polled by Reuters expect U.S. nonfarm payrolls
likely increased by 3 million jobs in June, which would be the
most since the government started keeping records in 1939.
    Offering some respite to gold, the dollar index        fell
    While major market moves are unlikely ahead of the U.S.
further support for safe-haven gold," CMC's McCarthy said.
ounce, platinum        rose 0.1% to $816.58, while silver       
 (Reporting by Brijesh Patel in Bengaluru; Editing by Shailesh
